Business
Kali-Extracts To Franchise Its Patented Cannabis Extraction Service Nationwide After President Trump Legalizes Hemp Farming
Kali-Extracts To Franchise Its Patented Cannabis Extraction Service Nationwide After President Trump Legalizes Hemp Farming.
About this update from Kali Inc
[{"type":"text","content":"\nDALLAS, Dec. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE --  Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans to launch a hemp-derived CBD extraction franchise business following President Trump signing the Farm Bill legalizing hemp farming into law.  KALY owns and operates a patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled 'METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT'.  The company has conducted numerous preclinical trials for a variety of disease therapies based on cannabis extracts derived from its cannabis process.  The company also has experience producing commercial extractions for infusion into nutrition and wellness products. “I don’t think any cannabis extractor has more credibility or experience than we do with our patented process and preclinical trial results,” said Frederick Ferri, CEO of Kali-Extracts. “Hemp farmers will need CBD extraction services and can’t afford to risk their crop with an inexperienced or first-time extractor.  Our franchise process will deploy trained extractors with a patented and proven process nationwide.”  Kali-Extracts plans to begin marketing the CBD extraction franchise in February.\n KALY produces pharmaceutical grade cannabis extracts that have been involved in multiple clinical trials in addition to utilizing its patented cannabis extraction process in the production of CBD infused nutrition and wellness products to include its own Hemp4mula and CBD infused waters produced by Puration, Inc. (“PURA”). KALY is partners with PURA and Nouveau Life Pharmaceuticals in a joint venture named US Cannabis Health for the purpose of together developing partnerships with pharmaceutical companies to develop cannabis pharmaceuticals.  US Cannabis Health recently announced its first agreement with Generex Biotechnology, Corp. To learn more about the KALY and NOUV project announced today, follow developments online at www.kali-extracts.com. Disclaimer/Safe Harbor:  This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. A...